TALZENNA (TALAZOPARIB TOSYLATE) — FDA Approval NDA211651 (PFIZER)
TALZENNA (TALAZOPARIB TOSYLATE) — FDA Approval NDA211651 (PFIZER) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TALZENNA; Active ingredients: TALAZOPARIB TOSYLATE; Application number: NDA211651.
| Brand name | TALZENNA |
|---|---|
| Active ingredients | TALAZOPARIB TOSYLATE |
| Application number | NDA211651 |
| Sponsor | PFIZER |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 6 |
| First approval date | 20181016 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →